Robert brings more than two decades of domestic and global experience in the ophthalmic space building organizations, driving successful drug development, and transacting companies and products to deliver shareholder value and improve patient outcomes

Amir has built a career in life sciences as a leader with over two and a half decades of drug development experience, focused on the clinical development, registration and commercialization of biopharmaceuticals and biologics in multiple therapeutic areas.

Dr. Pandey is Vice President, Research and Development at AsclepiX Therapeutics. Dr. Pandey is responsible for guiding scientific discovery and research of the company.

Jill joined AsclepiX with over 15 years of experience in corporate finance, financial planning and analysis in the pharmaceutical and healthcare industries.

Dr. Green is the Founder and Chief Technology Advisor of AsclepiX Therapeutics and responsible for guiding technical directions of the company.

Dr. Popel is the Founder and Chief Scientific Advisor of AsclepiX Therapeutics and responsible for guiding scientific directions of the company.